256 results on '"Saka, Esen"'
Search Results
2. Clinical predictors of Alzheimer's disease‐like brain atrophy in individuals with memory complaints
3. Cerebral vasomotor reactivity across the continuum of subjective cognitive impairment, amnestic mild cognitive impairment and probable Alzheimerʼs dementia: A transcranial Doppler and PET/MRI study
4. Contribution of functional dopamine D2 and D3 receptor variants to motor and non-motor symptoms of early onset Parkinson’s disease
5. Perspectives of Family Caregivers of People With Alzheimer's Disease on Caregiving Experience and Needs: A Qualitative Study.
6. Perspectives of Family Caregivers of People With Alzheimer's Disease on Caregiving Experience and Needs: A Qualitative Study
7. Modulation of Cerebellar-Cortical Connections in Multiple System Atrophy Type C by Cerebellar Repetitive Transcranial Magnetic Stimulation
8. Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum
9. The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN
10. Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
11. Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
12. Post‐inflammatory administration of N ‐acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease
13. Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson’s patients and genotype-phenotype correlations
14. Rhythm Control and Dementia in Patients With Atrial Fibrillation: A Role for Glymphatic System?
15. Sleep disorders and polysomnography findings in patients with autoimmune encephalitis
16. Progressive anterior operculum syndrome due to frontotemporal lobar degeneration
17. New mutations and genotype–phenotype correlation in late-onset Pompe patients
18. Cerebral vasomotor reactivity across the continuum of subjective cognitive impairment, amnestic mild cognitive impairment and probable Alzheimer's dementia: A transcranial Doppler and PET/MRI study
19. Cognitive profiling in relation to short latency afferent inhibition of frontal cortex in multiple system atrophy
20. Recrudescence of Deficits After Stroke: Clinical and Imaging Phenotype, Triggers, and Risk Factors
21. Dysregulation of CalDAG-GEFI and CalDAG-GEFII Predicts the Severity of Motor Side-Effects Induced by Anti-Parkinsonian Therapy
22. Two cases with mitochondrial membrane protein-associated neurodegeneration: genetic features and long-term clinical follow-up
23. What is new in nuclear medicine imaging for dementia
24. Multimodal brain imaging demonstrates that both amyloid burden and glucose metabolism predict the severity of cognitive impairment in patients with Alzheimer’s disease
25. Post-stroke totally recovery of tremor in a patient with Parkinson’s disease
26. Enhanced cued recall and clock drawing test performances differ in Parkinson's and Alzheimer's disease-related cognitive dysfunction
27. Antiepileptic treatment for anti-NMDA receptor encephalitis: the need for video-EEG monitoring
28. Use of Oral Nutritional Supplements in Neurology: General Principles, Special Practices
29. Comparative analysis of cognitive profiles of Huntington’s and Parkinson’s diseases
30. Alzheimer’s disease–related atrophy patterns in different definitons of subjective cognitive decline
31. Vitamin D deficiency is associated with decreased cognition independent from the disease status and AD morphology
32. Enhanced cued recall has a high utility as a screening test in the diagnosis of Alzheimer's disease and mild cognitive impairment in Turkish people
33. Hyperoxia potentiated sonothrombolysis as a method of acute ischemic stroke therapy
34. Recommendations to standardize preanalytical confounding factors in Alzheimerʼs and Parkinsonʼs disease cerebrospinal fluid biomarkers: an update
35. Short latency afferent inhibition in Parkinsonʼs disease patients with dementia
36. Comparative Analysis of Cognitive Profiles of Huntington’s and Parkinson’s Diseases
37. Modelling cognitive deficits in Parkinson's disease: Is CA2 a gateway for hippocampal synucleinopathy?
38. Reversible acute cognitive dysfunction induced by bilateral STN stimulation
39. The Sole Initial Imaging Finding in Creutzfeldt-Jacob Disease: Focal FDG-PET Hypometabolism
40. Cognitive dysfunction in relation to topography and burden of cerebral microbleeds
41. Adaptation of the Modified Mini-Mental State Examination (3MS) and Determination of Its Normative Values in Turkey
42. Higher alpha-synuclein aggregate density does not lead to more severe dopaminergic cell loss in the AAV-mediated overexpression model of Parkinson's Disease: A timecourse study.
43. The Role of the Dopamine β-hydroxylase Functional Polymorphism in Patients with Early-Onset Parkinson's Disease in the Turkish Population.
44. Familial adult onset myoclonic epilepsy associated with migraine
45. Synaptic loss predominates neuronal loss in a PD model of AAV-mediated alpha-synuclein overexpression in hippocampus and striatum
46. Cognitive dysfunction in relation to topography and burden of cerebral microbleeds
47. A Population-Based Study for the Standardization of the Turkish Version of the Modified Mini Mental State Examination (3MS) and Assessment of Certain Environmental Risk Factors for Dementia: Methodology and Sample Characteristics
48. Cognitive Dysfunction in Relation to Topography and Burden of Cerebral Microbleeds
49. Evaluation of cognitive performance and daily life activities in dementia patients with online cognitive tracking and exercise application.
50. Default Mode Network Connectivity Is Linked To Cognitive Functioning And Csf A Beta(1-42) Levels In Alzheimer'S Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.